The Senate bill would ban most settlements known as "reverse payments," in which a brand-name company pays a generic manufacturer to delay the introduction of the generic drug.
From: www.wibw.com
AP) -- Legislation aimed at speeding the availability of cheaper generic drugs has stalled in Congress in ...
Posted by Ruslan Abuzant at 6:43 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment